Novo CEO pressed by Senate to cut prices of weight problems, diabetic issues medications CEO Lars Fruergaard Jørgensen advised lawmakers the company would think about new talks with insurers about the listing charges of Wegovy and copyright if they pledge to maintain the medicines on their formularies. Given that some https://kethek.com/